Abstract PR010: First-in-class TRPV6 inhibitors for the treatment of prostate cancer

Authors: Kimberley Beaumont, Rebecca Pouwer, Raphael Rahmani, Matthew McLachlan, Claire Levrier, Rebecca Farrow, Mei Yeh, Therese Johnson, Malika Kumarasiri, Hasanthi Wijesekera, Grant Stuchbury, Terrie-Anne Cock, Andrew Harvey, Gregory Monteith, Brian Dymock

Published: 2023-06-02

DOI: 10.1158/1538-7445.prca2023-pr010

Source: Full article